INS and diabetes mellitus: The PI3K/AKT and MAPK signaling pathways can be compromised in people with diabetes, which can cause enhanced hepatic glucose production and decreased insulin sensitivity, implying a major role for these substrates in maintaining glucose balance [123] (Figure 1).